Colon Cancer, Version 2.2018

By A. Benson, A. Venook, M. Al-Hawary, L. Cederquist, Yi-Jen Chen, K. Ciombor, S. Cohen, H. Cooper, D. Deming, P. Engstrom and 26 more. The Journal of the National Comprehensive Cancer Network, 2018

865 citations recorded by the source corpus.

The NCCN Guidelines for Colon Cancer provide recommendations regarding diagnosis, pathologic staging, surgical management, perioperative treatment, surveillance, management of recurrent and metastatic disease, and survivorship. These NCCN Guidelines Insights summarize the NCCN Colon Cancer Panel discussions for the 2018 update of the guidelines regarding risk stratification and adjuvant treatment for patients with stage III colon cancer, and treatment of BRAF V600E mutation–positive metastatic colorectal cancer with regimens containing vemurafenib.

Subfields: Oncology, Pathology and Forensic Medicine

View Paper: https://www.semanticscholar.org/paper/554b34d1a94d243a4367cad21c33bf6b0e9fb3a5

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. P. Pimentel-Nunes
2. D. Libânio
3. P. Bhandari
4. B. Bastiaansen
5. Raf Bisschops
6. M. Dinis-Ribeiro
7. M. Bourke
8. G. Esposito

Citations in the corpus

• Endoscopic submucosal dissection for superficial gastrointestinal lesions: European Society of Gastrointestinal Endoscopy (ESGE) Guideline - Update 2022. (2022, background): “If technical success is confirmed, ESGE then recommends further surveillance in accordance with polypectomy and colorectal cancer surveillance guidelines [238, 239].”